Small Molecule Drug Discovery Market Outlook, Trends And Future Opportunities (2024-2031)

Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology Cardiovascular Diseases Infectious Diseases Metabolic Disorders Neurological Disorders Autoimmune Diseases Others), By Drug Type (Small Molecule Synthetic Drugs Small Molecule Biologics Small Molecule Vaccines Small Molecule Gene Therapies Peptides Oligonucleotides Others), By Target Class (G-protein-coupled Receptors (GPCRs) Kinases Proteases Ion Channels Nuclear Receptors Enzymes Others), By Molecule Type (Synthetic Compounds Natural Compounds Peptides Oligonucleotides Others), By Phase of Development (Preclinical Phase I Phase II Phase III Approved/Marketed Drugs), By Service Type (Lead Identification Services Lead Optimization Services Candidate Selection Services Bioavailability and Solubility Studies Others), By Technology (High-throughput Screening (HTS) Computer-aided Drug Design (CADD) Combinatorial Chemistry Bioinformatics Structural Biology Nanotechnology Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

本报告从供需两端对小型分子药物发现市场进行了全面审视，涵盖治疗领域（如肿瘤学、心血管疾病、传染病、代谢性疾病、神经系统疾病、自身免疫性疾病及其他）、药物类型（如小分子合成药物、小分子生物制剂、小分子疫苗、小分子基因疗法、肽类、寡核苷酸及其他）、靶标类别（如G蛋白偶联受体（GPCRs）、激酶、蛋白酶、离子通道、核受体、酶及其他）、分子类型（如合成化合物、天然化合物、肽类、寡核苷酸及其他）、开发阶段（如临床前、I期、II期、III期、批准/上市药物）、服务类型（如先导化合物识别服务、先导化合物优化服务、候选药物选择服务、生物利用度和溶解度研究及其他）、技术（如高通量筛选（HTS）、计算机辅助药物设计（CADD）、组合化学、生物信息学、结构生物学、纳米技术及其他）以及区域（如北美、欧洲、亚太地区、拉丁美洲、中东及非洲）等多个维度，旨在辅助决策者作出明智的选择。